AEPROMED INNOVATION CORP., LTD.
Area: Government, Academia and Research Institutes
Booth No: N602
Website: https://www.aepromed.com/
Exhibitor Profile
AeproMED: Revolutionizing Inhalation Therapy
AIRHYPER™ Platform tackles imprecise dosing and adherence gaps. Using AFDT™ and DSMT™, we provide a Device-Drug Co-Validation chain:
1. AniFree™: CE-certified non-anesthetic animal system for dose translation.
2. Testing: ISO 27427 / USP 1601 compliant, pursuing TAF (ISO 17025).
3. NEBreath™: TFDA-cleared nebulizer with high efficiency and low residual volume for home care.
We bridge the translational gap via our “Drug + Device + Data” model.
Brands
AeproMED
Exhibit Products
-
BREEZONE™ | Personal Aroma Nebulizer
-
In Vitro Aerosol Performance Testing Services [ISO27427] [USP1601]
-
AniFree™ | Laboratory Animal Nebulization Device
-
NEBreath™ | Vibrating Mesh Nebulizer
Exhibitor Press Release
- AeproMED’s NEBreath™ Receives TFDA Medical Device Approval 2026-05-19
- From Hospital to Home: AeproMED Partners with NTU Hospital Yunlin Branch to Advance Smart Inhalation 2026-05-19
Exhibitors you may be interested in
Highest Rated